/PRNewswire/ Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody.
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
The biotech focused on novel antibody therapies will now be called Spyre Therapeutics, as part of a rebrand to expand its inflammatory bowel disease pipeline.
These works of art by local artists in San Diego bring inspirational, creative, and quirky designs to our neighborhood streets. See their designs here.